
Probing Pulmonary Hypertension: The Promise of Genetic Testing
Genetic testing uncovers mutations in pulmonary hypertension, aiding diagnosis and personalized treatment. Explore its role in managing this complex condition.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Genetic testing uncovers mutations in pulmonary hypertension, aiding diagnosis and personalized treatment. Explore its role in managing this complex condition.

Genetic testing uncovers the key mutations in pulmonary hypertension, primary, 3, guiding personalized treatments and enhancing diagnostic accuracy and research advancements.

Explore how genetic testing aids in diagnosing Pulmonary Hypertension, Primary, 4, offering early detection, personalized treatment, and better management strategies.

Explore renal-hepatic-pancreatic dysplasia 2, a rare genetic disorder. Learn how genetic testing aids early diagnosis, personalized care, and family planning.

Unlock the potential of genetic testing for Retinitis Pigmentosa 66. Gain insights into diagnosis, inheritance patterns, and future therapies for improved management.

Unravel CARD11 deficiency in SCID with genetic testing. Early detection, personalized treatments, and family planning insights improve outcomes significantly.

Explore the impact of CORO1A deficiency on SCID, the role of genetic testing in early diagnosis, personalized treatments, and the importance of genetic counseling.

Explore the genetic factors behind severe congenital hypochromic anemia with ringed sideroblasts and learn how genetic testing aids in diagnosis and personalized treatment.